Travis Walter

Travis Walter is an experienced pharmaceutical representative with a career spanning over two decades in the gastrointestinal and metabolic disorder sectors. Currently serving as a Senior GI Representative at QOL Medical LLC since March 2021, Travis has previously held the position of Territory Manager in the GI MED Division at Takeda Pharmaceuticals from June 2010 to October 2020, where notable products launched include Motegrity. Prior to this role, Travis worked at TAP Pharmaceuticals for ten years, where contributions included launching significant products such as Dexilant and Amitiza, and promoting Prevacid and its formulations. Travis holds a Bachelor's degree in Education from Virginia Tech.